ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31

ACADIA PHARMACEUTICALS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$19.80+0.68 (+3.56%)

Close on Oct 19, 2026

Market cap: $3.42B
P/E (TTM): 9.0
Dividend yield: –

ACADIA PHARMACEUTICALS INC balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31
Cash & Equivalents	178	320	189	115	147	326	190	135	69	164	102	62	12	58	6.89	6.85	18	21
Short-Term Investments	642	436	250	302	373	306	508	339	272	365	113	261	174	50	24	30	–	–
Cash & Short-Term Investments	820	756	439	417	521	632	697	474	341	529	215	322	186	108	31	37	18	21
Receivables	121	99	98	62	64	48	36	26	17	5.90	–	–	–	–	–	–	–	–
Inventory	111	92	40	12	14	9.68	6.34	4.07	5.25	4.18	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	60	56	39	21	24	26	19	21	8.46	7.55	2.22	1.17	1.82	0.58	0.90	0.76	–	–
Total Current Assets	1,062	938	616	508	618	718	760	526	373	548	219	325	188	109	32	38	–	–
Property, Plant & Equipment	7.51	4.22	4.61	6.02	8.05	9.16	3.18	3.31	2.66	3.08	2.20	0.55	0.58	0.04	0.15	0.43	–	–
Gross Property, Plant & Equipment	17	14	14	14	14	13	8.51	7.51	6.89	6.49	4.99	2.69	2.55	4.78	6.29	–	–	–
Accumulated Depreciation	-9.48	-10	-9.56	-8.10	-6.18	-3.95	-5.33	-4.21	-4.23	-3.41	-2.79	-2.14	-1.97	-4.73	-6.14	–	–	–
Operating Lease Right-of-Use Assets	47	47	52	56	58	47	9.52	0	–	–	–	–	–	–	–	–	–	–
Intangible Assets	109	120	65	0	0	1.11	2.59	4.06	5.54	7.02	–	–	–	–	–	–	–	–
Deferred Tax Assets	250	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	3.90	0.36	0.48	7.59	4.00	1.68	2.86	1.90	0.35	0.79	0.33	0.29	0.18	–	0.01	0.12	–	–
Total Assets	1,564	1,188	749	588	700	783	783	540	385	561	222	325	189	109	32	38	–	–
Accounts Payable	11	16	18	13	6.88	8.49	7.22	3.17	8.79	3.91	1.67	2.02	0.37	1.38	1.96	1.97	–	–
Accrued Expenses	266	379	237	113	89	97	68	56	40	36	20	14	6.55	4.14	3.50	3.22	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.03	0.08	–	–
Current Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.03	0.08	–	–
Current Portion of Leases	12	9.96	9.41	9.31	8.30	5.09	3.43	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	8.71	0.38	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	–	–	–	–	2.64	–	–	0.06	0.43	0.67	0.69	–	–
Total Current Liabilities	277	395	254	126	96	106	75	60	49	43	22	16	6.98	5.95	6.17	5.96	–	–
Long-Term Leases	41	42	48	53	56	44	6.36	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	52	52	57	62	64	50	9.80	0	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	11	11	12	13	14	13	2.51	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	19	18	15	9.07	7.03	5.18	2.86	1.56	–	–	–	–	–	–	–	0.12	–	–
Total Liabilities	337	455	317	187	159	156	84	61	49	43	22	16	6.99	5.95	8.75	8.71	–	–
Total Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.03	0.08	–	–
Preferred Stock	0	0	0	0	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	–	–
Additional Paid-In Capital	3,039	2,937	2,863	2,771	2,695	2,613	2,403	1,948	1,559	1,452	862	808	588	453	370	353	–	–
Retained Earnings	-1,813	-2,204	-2,431	-2,370	-2,154	-1,986	-1,704	-1,469	-1,224	-934	-663	-498	-406	-368	-347	-324	–	–
Comprehensive Income & Other	1.45	0.29	0.02	-0.98	-0.19	0.04	0.30	-0.37	-0.40	0.11	0.01	-0.01	0.05	0.00	0.01	0.51	–	–
Shareholders' Equity	1,227	733	432	400	541	627	699	479	335	518	200	309	182	85	23	30	12	53
Total Equity	1,227	733	432	400	541	627	699	479	335	518	200	309	182	85	23	30	12	53
Total Liabilities & Equity	1,564	1,188	749	588	700	783	783	540	385	561	222	325	189	109	32	38	–	–
Shares Outstanding(shares)	170	167	165	162	161	160	155	144	124	121	102	100	91	73	53	39	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 91.1%
Operating margin: 7.6%
Net margin: 33.4%
Return on equity, FY2025: 39.9%

Financial strength

Current ratio: 3.39
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 106.5%

Valuation

P/E ratio: 9.0
Price to sales: 3.01
Price to book: 2.62
Dividend yield: –